Image

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

Prospective non-randomized intervention case control study on patients with a BMI > 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.

Eligibility

Inclusion Criteria case group:

  • Age > 18 years
  • BMI >35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
  • Able to give written informed consent.

Inclusion criteria control group:

  • Age > 18 years
  • BMI >35 kg/m2 with no wish to undergo bariatric surgery.
  • Able to give written informed consent.

Exclusion Criteria:

  • Active viral hepatitis
  • Not willing or able to consent
  • Contraindications to liver biopsy

Study details
    Non-Alcoholic Fatty Liver Disease
    Metabolic Encephalopathy
    Obesity
    Morbid
    Non-alcoholic Steatohepatitis

NCT03535142

Hospital of South West Jutland

26 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.